Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 9604861)

Published in Diabetes on June 01, 1998

Authors

M Shiota1, P Galassetti, M Monohan, D W Neal, A D Cherrington

Author Affiliations

1: Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0615, USA. masakazu.shiota@mcmail.vanderbilt.edu

Articles citing this

Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev (2009) 2.65

Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals. Am J Clin Nutr (2008) 2.05

Is the fructose index more relevant with regards to cardiovascular disease than the glycemic index? Eur J Nutr (2007) 1.24

Dynamic profiling of the glucose metabolic network in fasted rat hepatocytes using [1,2-13C2]glucose. Biochem J (2004) 1.03

A physiological increase in the hepatic glycogen level does not affect the response of net hepatic glucose uptake to insulin. Am J Physiol Endocrinol Metab (2009) 0.93

HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease. Nature (2015) 0.89

Normal roles for dietary fructose in carbohydrate metabolism. Nutrients (2014) 0.87

Hepatic intralobular mapping of fructose metabolism in the rat liver. Biochem J (2000) 0.85

Hepatic glycogen supercompensation activates AMP-activated protein kinase, impairs insulin signaling, and reduces glycogen deposition in the liver. Diabetes (2011) 0.84

Normal glucose metabolism in carnivores overlaps with diabetes pathology in non-carnivores. Front Endocrinol (Lausanne) (2013) 0.82

A hepatic protein modulates glucokinase activity in fish and avian liver: a comparative study. J Comp Physiol B (2009) 0.77

Continuous low-dose fructose infusion does not reverse glucagon-mediated decrease in hepatic glucose utilization. Metabolism (2010) 0.77

Hepatic glucose sensing is impaired, but can be normalized, in people with impaired fasting glucose. J Clin Endocrinol Metab (2014) 0.76

John P. Peters: his role in diabetes, research, and patient care. Yale J Biol Med (2002) 0.75

Articles by these authors

Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem (1999) 10.14

Exercise-induced asthma in figure skaters. Chest (1996) 2.19

The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes (1997) 1.64

The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog. J Clin Invest (1976) 1.59

Oxygen effect on O2 deficit and VO2 kinetics during exercise in obstructive pulmonary disease. J Appl Physiol (1985) (1995) 1.55

A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Diabetes (1996) 1.53

Effect of glucagon on glucose production during insulin deficiency in the dog. J Clin Invest (1978) 1.52

Nutritional state and exercise tolerance in patients with COPD. Chest (1995) 1.52

Gluconeogenesis: methodological approaches in vivo. Fed Proc (1977) 1.47

Relationship between the plasma glucose level and glucose uptake in the conscious dog. Metabolism (1978) 1.44

Substrate-induced nuclear export and peripheral compartmentalization of hepatic glucokinase correlates with glycogen deposition. Int J Exp Diabetes Res (2001) 1.44

Studies on the alpha-andrenergic activation of hepatic glucose output. II. Investigation of the roles of adenosine 3':5'-monophosphate and adenosine 3':5'-monophosphate-dependent protein kinase in the actions of phenylephrine in isolated hepatocytes. J Biol Chem (1976) 1.43

Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism. J Biol Chem (1997) 1.43

Role of brain in counterregulation of insulin-induced hypoglycemia in dogs. Diabetes (1989) 1.42

Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog. J Clin Invest (1996) 1.33

Physiologic action of glucagon on liver glucose metabolism. Diabetes Obes Metab (2011) 1.32

Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man. J Clin Endocrinol Metab (1979) 1.28

Counterregulation during hypoglycemia is directed by widespread brain regions. Diabetes (1993) 1.28

Absorption and disposition of a glucose load in the conscious dog. Am J Physiol (1982) 1.27

Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon. J Clin Invest (1978) 1.26

Intraportal glucose delivery alters the relationship between net hepatic glucose uptake and the insulin concentration. J Clin Invest (1991) 1.22

Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism. Diabetes (2001) 1.19

Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man. J Clin Invest (1977) 1.19

Effects of gender on neuroendocrine and metabolic counterregulatory responses to exercise in normal man. J Clin Endocrinol Metab (2000) 1.18

Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes (1998) 1.18

Hypoglycemia in IDDM. Diabetes (1989) 1.15

Sources of carbon for hepatic glycogen synthesis in the conscious dog. J Clin Invest (1991) 1.15

Effects of antecedent hypoglycemia on subsequent counterregulatory responses to exercise. Diabetes (2000) 1.15

Role of insulin in the regulation of leucine kinetics in the conscious dog. J Clin Invest (1982) 1.15

Body fat and circulating leukocytes in children. Int J Obes (Lond) (2006) 1.14

Effect of glucose, independent of changes in insulin and glucagon secretion, on alanine metabolism in the conscious dog. J Clin Invest (1980) 1.14

Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog. J Clin Invest (1987) 1.13

Effect of arginine on glucose turnover and plasma free fatty acids in normal dogs. Diabetes (1973) 1.12

The roles of insulin, glucagon, and free fatty acids in the regulation of ketogenesis in dogs. Diabetes (1977) 1.10

Differential time course of glucagon's effect on glycogenolysis and gluconeogenesis in the conscious dog. Diabetes (1981) 1.09

The effect of somatostatin on glucose uptake and production by rat tissues in vitro. Diabetes (1977) 1.08

Hepatic fuel metabolism during muscular work: role and regulation. Am J Physiol (1991) 1.07

Acute fructose administration decreases the glycemic response to an oral glucose tolerance test in normal adults. J Clin Endocrinol Metab (2000) 1.06

Effect of interaction between insulin and glucagon on glucose turnover and FFA concentration in normal and depancreatized dogs. Metabolism (1974) 1.06

Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans. Diabetes (2000) 1.06

Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog. Am J Physiol (1993) 1.06

Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. Am J Physiol (1989) 1.06

Control of hepatic glucose output by glucagon and insulin in the intact dog. Biochem Soc Symp (1978) 1.05

Compartmental modeling of glucagon kinetics in the conscious dog. Metabolism (1995) 1.05

Glucokinase gene locus transgenic mice are resistant to the development of obesity-induced type 2 diabetes. Diabetes (2001) 1.04

Interaction between insulin and glucose-delivery route in regulation of net hepatic glucose uptake in conscious dogs. Diabetes (1990) 1.03

Insulin as a mediator of hepatic glucose uptake in the conscious dog. Am J Physiol (1982) 1.02

Acute fructose administration improves oral glucose tolerance in adults with type 2 diabetes. Diabetes Care (2001) 1.01

A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake. Am J Physiol (1998) 1.01

Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region. Am J Physiol Endocrinol Metab (2004) 1.00

Autoregulation of hepatic glucose production. Eur J Endocrinol (1998) 1.00

Evidence that the brain of the conscious dog is insulin sensitive. J Clin Invest (1995) 0.99

Regulation of net hepatic glucose uptake in vivo. Annu Rev Physiol (1992) 0.99

Arginine infusion in dogs. Model for the roles of insulin and glucagon in regulating glucose turnover and free fatty acid levels. Diabetes (1974) 0.99

Importance of hypoglycemia-induced glucose production during isolated glucagon deficiency. Am J Physiol (1979) 0.98

Disposition of a mixed meal by the conscious dog. Am J Physiol (1994) 0.97

Exercise-induced fall in insulin and hepatic carbohydrate metabolism during muscular work. Am J Physiol (1989) 0.96

Effect of hyperglycemia independent of changes in insulin or glucagon on lipolysis in the conscious dog. Metabolism (1980) 0.96

Effect of hyperglucagonemia on hepatic glycogenolysis and gluconeogenesis after a prolonged fast. Am J Physiol (1990) 0.95

Mechanisms of hormonal regulation of liver metabolism. Adv Cyclic Nucleotide Res (1981) 0.95

Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo. J Clin Invest (1991) 0.95

Ketone body turnover and net hepatic ketone production in fasted and diabetic dogs. Am J Physiol (1978) 0.95

Hepatic denervation does not significantly change the response of the liver to glucagon in conscious dogs. Am J Physiol (1995) 0.94

Differential effect of amino acid infusion route on net hepatic glucose uptake in the dog. Am J Physiol (1999) 0.94

Importance of intrahepatic mechanisms to gluconeogenesis from alanine during exercise and recovery. Am J Physiol (1988) 0.94

Similar dose responsiveness of hepatic glycogenolysis and gluconeogenesis to glucagon in vivo. Diabetes (1987) 0.94

Effect of a mixed meal on hepatic lactate and gluconeogenic precursor metabolism in dogs. Am J Physiol (1984) 0.94

A negative arterial-portal venous glucose gradient increases net hepatic glucose uptake in euglycemic dogs. Am J Physiol (1999) 0.94

Comparison of the direct and indirect effects of epinephrine on hepatic glucose production. J Clin Invest (1997) 0.93

Insulin, glucagon, and glucose as regulators of hepatic glucose uptake and production in vivo. Diabetes Metab Rev (1987) 0.93

Pulsatility does not alter the response to a physiological increment in glucagon in the conscious dog. Am J Physiol (1994) 0.93

Effects of small changes in glucagon on glucose production during a euglycemic, hyperinsulinemic clamp. Metabolism (1991) 0.93

Role of glucagon suppression on gluconeogenesis during insulin treatment of the conscious diabetic dog. Diabetologia (1987) 0.92

Effect of epinephrine on glycogenolysis and gluconeogenesis in conscious overnight-fasted dogs. Am J Physiol (1984) 0.92

Role of hepatic nerves in response of liver to intraportal glucose delivery in dogs. Am J Physiol (1992) 0.91

Physiological changes in circulating glucagon alter hepatic glucose disposition during portal glucose delivery. Am J Physiol (1997) 0.91

Effects of morphine on glucose homeostasis in the conscious dog. J Clin Invest (1984) 0.90

Regulation of lipolysis and ketogenesis by norepinephrine in conscious dogs. Am J Physiol (1991) 0.90

Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious dogs. Diabetes (1988) 0.90

Effects of insulin on the counterregulatory response to equivalent hypoglycemia in normal females. Am J Physiol (1993) 0.89

The roles of insulin and glucagon in the regulation of gluconeogenesis in the postabsorptive dog. Diabetes (1977) 0.89

Exercise-induced fall in insulin and increase in fat metabolism during prolonged muscular work. Diabetes (1989) 0.89

Effects of fasting on gluconeogenesis from alanine in nondiabetic man. Diabetes (1979) 0.89